News

Investing Snacks7h

Bristol-Myers Squibb Bets Big on Schizophrenia Drug

Jim Cramer, a stalwart of stock market commentary, recently shifted gears on Bristol-Myers Squibb, pegging his hopes on their ...
StockStory.org on MSN13h

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q1 Earnings?

Bristol-Myers Squibb’s shares (currently trading at $46.80) have posted a disappointing 18% loss, well below the S&P 500’s ...